Loading interface...

Neo Recormon 3000 IU Injection

Manufactured byRoche India
ContainsEpoetin Beta
Description
Neo Recormon 3000 IU Injection is used to treat a lower than normal count of red blood cells (anemia) caused by chronic kidney failure, a condition where the kidneys slowly and permanently stop functioning over a period of time. It is also used to treat anemia caused by chemotherapy medications (cancer drugs) in patients suffering from certain specific types of cancer.

Side effects

Major & minor side effects for Neo Recormon 3000 IU Injection

  • Diarrhea
  • Skin rash and itching
  • Difficulty in breathing
  • Back pain
  • Swelling of the face, arms, hands, lower legs, or feet
  • Stomach pain
  • Redness, swelling, bruising, itching, or a lump at the injection site
  • Headache
  • Cough
  • Nausea and vomiting

Uses of Neo Recormon 3000 IU Injection

What is it prescribed for?

  • Chronic kidney disease associated anemia
  • Chemotherapy associated anemia
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of this medicine can be observed after several days of administration.
  • How long do the effects of this medicine last?
    The time for which the effect of this medicine persists is subjected to vary depending on the intended use.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine. Your doctor may advise you to discontinue the medicine or to discontinue breastfeeding based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a history of severe allergic reactions to epoetin beta or any other inactive ingredients present in the formulation.

Pure red cell aplasia

This medicine is not recommended for use in patients with pure red cell aplasia (PRCA) that begins after treatment with darbepoetin alfa or other erythropoietin protein drugs.

Uncontrolled hypertension

This medicine is not recommended for use in patients with an uncontrolled high blood pressure since it may worsen the patient's condition.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. Your doctor will determine the best course of treatment after evaluating the potential benefits and risks associated with the use of this medicine. Your doctor may advise you to discontinue the medicine or to discontinue breastfeeding based on your clinical condition.
General warnings

Cardiovascular diseases

This medicine should be used with extreme caution in patients with a history of cardiovascular diseases due to the increased risk of serious and life-threatening adverse effects. Close monitoring of the clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the patient's clinical condition.

Other medicines

This medicine may interact with many other medicines and may cause severe adverse effects. Hence, it is advised that you report all your current medicines, including any herbs and supplements, to the doctor before beginning treatment with this medicine.

Ongoing cancer treatment

This medicine is not recommended for use in cancer patients who are being treated with biological products or radiation therapy. It is also not recommended for use in cancer patients who are receiving myelosuppressive therapy for a curable form of cancer.

Serious allergic reactions

This medicine may cause severe and life-threatening allergic reactions in some patients. Use should be discontinued immediately and permanently if any such reactions occur.

Not for immediate effect

This medicine should not be used in cases where an immediate increase in the red blood cell count is desired.

Missed Dose

Contact your doctor if you have missed a scheduled dose of this medicine and follow all the instructions given.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Cisplatin

Cyclosporine

Cyclophosphamide

Etoposide

Lenalidomide

Disease interactions

Hypertension

This medicine is not recommended for use in patients suffering from uncontrolled high blood pressure. Blood pressure should be adequately controlled before beginning therapy with this medicine. Close monitoring of blood pressure is necessary during treatment with this medicine. Aggressive antihypertensive therapy, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Seizure disorders

This medicine should be used with caution in patients suffering from seizure disorders since it may worsen the patient's condition. You may require a dose adjustment and more frequent clinical monitoring to safely use these medicines together. Replacement with a suitable alternative may be necessary based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Administer this medicine exactly as prescribed by the doctor. It is advised to always administer this medicine in the presence of your doctor or a trained healthcare professional. Do not use this medicine in larger or smaller quantities than recommended. Ensure that the course of treatment is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Usage does not depend on food timings

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine works by stimulating the bone marrow and as a result production of red blood cells is increased.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Recombinant human erythropoietins

Schedule

Schedule H

NeoRecormon 10,000 IU solution for injection in pre-filled syringe - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2019 [cited 23 August 2019]. Available from:

https://www.medicines.org.uk/emc/product/10496/smpc

Recombinant human epoetin beta in the treatment of renal anemia [Internet]. PubMed Central (PMC). 2019 [cited 23 August 2019]. Available from:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386355/
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 23 Aug 2019

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.